Tigecycline: Place in therapy and important considerations

被引:2
作者
Garrelts, JC [1 ]
Schroeder, T [1 ]
机构
[1] Wesley Med Ctr, Clin & Res Serv, Wichita, KS 67214 USA
关键词
D O I
10.2146/ajhp060206
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1233 / 1233
页数:1
相关论文
共 5 条
[1]   Oritavancin and tigecycline: Investigational antimicrobials for multidrug-resistant bacteria [J].
Guay, DRP .
PHARMACOTHERAPY, 2004, 24 (01) :58-68
[2]  
*INF DIS SOC AM, BAD BUGS NO DRUGS
[3]   Tigecycline: A new glycylcycline antimicrobial agent [J].
Kasbekar, N .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (13) :1235-1243
[4]   Tigecycline: A new glycylcycline for treatment of serious infections [J].
Noskin, GA .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S303-S314
[5]   Overview of antibiotic use and resistance: Setting the stage for tigecycline [J].
Zinner, SH .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S289-S292